vs
EPAM Systems（EPAM）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是EPAM Systems的1.0倍（$1.4B vs $1.4B），瑞思迈净利率更高（27.6% vs 7.8%，领先19.8%），EPAM Systems同比增速更快（12.8% vs 11.0%），过去两年EPAM Systems的营收复合增速更高（9.9% vs 7.9%）
EPAM Systems是总部位于美国宾夕法尼亚州纽敦的企业，核心业务涵盖软件工程服务、数字平台研发、数字产品设计三大板块，同时是MACH联盟的创始成员，在全球数字化服务赛道拥有深厚的技术积累与行业认可度。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
EPAM vs RMD — 直观对比
营收规模更大
RMD
是对方的1.0倍
$1.4B
营收增速更快
EPAM
高出1.8%
11.0%
净利率更高
RMD
高出19.8%
7.8%
两年增速更快
EPAM
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.4B |
| 净利润 | $109.4M | $392.6M |
| 毛利率 | 30.1% | 61.8% |
| 营业利润率 | 10.6% | 34.6% |
| 净利率 | 7.8% | 27.6% |
| 营收同比 | 12.8% | 11.0% |
| 净利润同比 | 5.9% | 13.9% |
| 每股收益（稀释后） | $1.97 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPAMRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B |
净利润EPAMRMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | $109.4M | $392.6M | ||
| Q3 25 | $106.8M | $348.5M | ||
| Q2 25 | $88.0M | $379.7M | ||
| Q1 25 | $73.5M | $365.0M | ||
| Q4 24 | $103.3M | $344.6M | ||
| Q3 24 | $136.3M | $311.4M | ||
| Q2 24 | $98.6M | $292.2M |
毛利率EPAMRMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | 30.1% | 61.8% | ||
| Q3 25 | 29.5% | 61.5% | ||
| Q2 25 | 28.8% | 60.8% | ||
| Q1 25 | 26.9% | 59.3% | ||
| Q4 24 | 30.4% | 58.6% | ||
| Q3 24 | 34.6% | 58.6% | ||
| Q2 24 | 29.3% | 58.5% |
营业利润率EPAMRMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | 10.6% | 34.6% | ||
| Q3 25 | 10.4% | 33.4% | ||
| Q2 25 | 9.3% | 33.7% | ||
| Q1 25 | 7.6% | 33.0% | ||
| Q4 24 | 10.9% | 32.5% | ||
| Q3 24 | 15.2% | 31.6% | ||
| Q2 24 | 10.5% | 31.2% |
净利率EPAMRMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | 7.8% | 27.6% | ||
| Q3 25 | 7.7% | 26.1% | ||
| Q2 25 | 6.5% | 28.2% | ||
| Q1 25 | 5.6% | 28.3% | ||
| Q4 24 | 8.3% | 26.9% | ||
| Q3 24 | 11.7% | 25.4% | ||
| Q2 24 | 8.6% | 23.9% |
每股收益（稀释后）EPAMRMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | $1.97 | $2.68 | ||
| Q3 25 | $1.91 | $2.37 | ||
| Q2 25 | $1.56 | $2.58 | ||
| Q1 25 | $1.28 | $2.48 | ||
| Q4 24 | $1.80 | $2.34 | ||
| Q3 24 | $2.37 | $2.11 | ||
| Q2 24 | $1.70 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.3B | $1.4B |
| 总债务越低越好 | — | $663.8M |
| 股东权益账面价值 | $3.7B | $6.3B |
| 总资产 | $4.9B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资EPAMRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $1.2B | $932.7M | ||
| Q4 24 | $1.3B | $521.9M | ||
| Q3 24 | $2.1B | $426.4M | ||
| Q2 24 | $1.8B | $238.4M |
总债务EPAMRMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M |
股东权益EPAMRMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | $3.7B | $6.3B | ||
| Q3 25 | $3.7B | $6.1B | ||
| Q2 25 | $3.7B | $6.0B | ||
| Q1 25 | $3.6B | $5.5B | ||
| Q4 24 | $3.6B | $5.3B | ||
| Q3 24 | $3.6B | $5.2B | ||
| Q2 24 | $3.4B | $4.9B |
总资产EPAMRMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | $4.9B | $8.5B | ||
| Q3 25 | $4.8B | $8.3B | ||
| Q2 25 | $4.7B | $8.2B | ||
| Q1 25 | $4.7B | $7.6B | ||
| Q4 24 | $4.8B | $7.1B | ||
| Q3 24 | $4.5B | $7.2B | ||
| Q2 24 | $4.2B | $6.9B |
负债/权益比EPAMRMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $282.9M | — |
| 自由现金流经营现金流 - 资本支出 | $268.1M | — |
| 自由现金流率自由现金流/营收 | 19.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | 2.59× | — |
| 过去12个月自由现金流最近4个季度 | $612.7M | — |
8季度趋势，按日历期对齐
经营现金流EPAMRMD
| Q2 26 | — | — | ||
| Q4 25 | $282.9M | $339.7M | ||
| Q3 25 | $294.7M | $457.3M | ||
| Q2 25 | $53.2M | $538.8M | ||
| Q1 25 | $24.2M | $578.7M | ||
| Q4 24 | $130.3M | $308.6M | ||
| Q3 24 | $242.0M | $325.5M | ||
| Q2 24 | $57.0M | $440.1M |
自由现金流EPAMRMD
| Q2 26 | — | — | ||
| Q4 25 | $268.1M | $311.2M | ||
| Q3 25 | $286.4M | $414.4M | ||
| Q2 25 | $43.4M | $508.2M | ||
| Q1 25 | $14.8M | $557.9M | ||
| Q4 24 | $114.5M | $288.0M | ||
| Q3 24 | $237.0M | $307.7M | ||
| Q2 24 | $52.3M | $415.2M |
自由现金流率EPAMRMD
| Q2 26 | — | — | ||
| Q4 25 | 19.0% | 21.9% | ||
| Q3 25 | 20.5% | 31.0% | ||
| Q2 25 | 3.2% | 37.7% | ||
| Q1 25 | 1.1% | 43.2% | ||
| Q4 24 | 9.2% | 22.5% | ||
| Q3 24 | 20.3% | 25.1% | ||
| Q2 24 | 4.6% | 33.9% |
资本支出强度EPAMRMD
| Q2 26 | — | — | ||
| Q4 25 | 1.1% | 2.0% | ||
| Q3 25 | 0.6% | 3.2% | ||
| Q2 25 | 0.7% | 2.3% | ||
| Q1 25 | 0.7% | 1.6% | ||
| Q4 24 | 1.3% | 1.6% | ||
| Q3 24 | 0.4% | 1.5% | ||
| Q2 24 | 0.4% | 2.0% |
现金转化率EPAMRMD
| Q2 26 | — | — | ||
| Q4 25 | 2.59× | 0.87× | ||
| Q3 25 | 2.76× | 1.31× | ||
| Q2 25 | 0.60× | 1.42× | ||
| Q1 25 | 0.33× | 1.59× | ||
| Q4 24 | 1.26× | 0.90× | ||
| Q3 24 | 1.77× | 1.05× | ||
| Q2 24 | 0.58× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
